Nyxoah (NYXH) had the highest return between January 13, 2024 and February 6, 2024 by a small-cap US stock, returning 149.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Nyxoah (NYXH) | 1/13/2024 - 2/6/2024 | 149.55% |
Dave (DAVE) | 1/13/2024 - 2/6/2024 | 140.52% |
Astria Therapeutics (ATXS) | 1/13/2024 - 2/6/2024 | 113.86% |
Sezzle Inc Common Stock (SEZL) | 1/13/2024 - 2/6/2024 | 113.58% |
Eos Energy Enterprises (EOSEW) | 1/13/2024 - 2/6/2024 | 100% |
Dianthus Therapeutics (DNTH) | 1/13/2024 - 2/6/2024 | 87.59% |
Cullinan Oncology LLC (CGEM) | 1/13/2024 - 2/6/2024 | 75.9% |
Immunome (IMNM) | 1/13/2024 - 2/6/2024 | 71.19% |
Arcutis Biotherapeutics (ARQT) | 1/13/2024 - 2/6/2024 | 56.16% |
ASP Isotopes Inc Common Stock (ASPI) | 1/13/2024 - 2/6/2024 | 55% |
Eos Energy Enterprises (EOSE) | 1/13/2024 - 2/6/2024 | 47.5% |
Kodiak Sciences (KOD) | 1/13/2024 - 2/6/2024 | 44.71% |
Oric Pharmaceuticals (ORIC) | 1/13/2024 - 2/6/2024 | 44.54% |
Tyra Biosciences (TYRA) | 1/13/2024 - 2/6/2024 | 42.86% |
Akso Health Group ADR (AHG) | 1/13/2024 - 2/6/2024 | 42.5% |
Innodata (INOD) | 1/13/2024 - 2/6/2024 | 39.82% |
Neuropace (NPCE) | 1/13/2024 - 2/6/2024 | 39.56% |
Byrna Technologies (BYRN) | 1/13/2024 - 2/6/2024 | 38.68% |
Humacyte (HUMA) | 1/13/2024 - 2/6/2024 | 38.26% |
Kura Oncology (KURA) | 1/13/2024 - 2/6/2024 | 38.05% |
Intuitive Machines (LUNR) | 1/13/2024 - 2/6/2024 | 37.12% |
Olema Pharmaceuticals (OLMA) | 1/13/2024 - 2/6/2024 | 36.52% |
Dada Nexus (DADA) | 1/13/2024 - 2/6/2024 | 36.49% |
GigaCloud Technology Inc Class A Ordinary Shares (GCT) | 1/13/2024 - 2/6/2024 | 36.04% |
Cerus (CERS) | 1/13/2024 - 2/6/2024 | 35.15% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
